A Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Doses of Prosetin in Healthy Volunteers and Participants With ALS

Active, not recruiting

Plain-English translation of NCT05279755 on ClinicalTrials.gov ↗ · Source last updated April 2026 · How we translate trials

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(4 sites)

United States

Massachusetts General Hospital, Boston, Massachusetts

Worldwide Clinical Trials Early Phase Services, San Antonio, Texas

Canada

The Neuro - Montréal Neurological Institute-Hospital, Montreal, Quebec

Netherlands

University Medical Center Utrecht, Utrecht, Utrecht